NurrOn Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related incurable human disorders. NurrOn is focused on discovering and developing innovative treatments that have the potential to improve clinical outcomes in PD patients. The greatest unmet medical need in PD is to slow or prevent disease...
NurrOn Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related incurable human disorders. NurrOn is focused on discovering and developing innovative treatments that have the potential to improve clinical outcomes in PD patients. The greatest unmet medical need in PD is to slow or prevent disease progression. Through targeting Nurr1, the master regulator for dopaminergic neuron development and maintenance, we aim to develop a paradigm-changing PD treatment to improve patient's quality of life.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.